for Investors
for Partners
for Media
Main contents starts here
What's New
- March 5, 2010
KAPIDEX™ (dexlansoprazole) Renamed DEXILANT™ in U.S. to Avoid Name Confusion - March 3, 2010
Lundbeck and Takeda finalise plans to initiate phase III pivotal clinical trials with Lu AA21004 and Lu AA24530 - February 23, 2010
Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity
Stock Performance
TSE 3/15 10:20
- Last
- 4,155
- Change
- +20
